A phase 3, international, multicenter, randomized, controlled trial of selective index lymph node resection versus therapeutic lymph node dissection after neoadjuvant immunotherapy for stage IIIB-D melanoma (MSLT-3/S2601/EORTC2519).
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Maria Gonzalez, Georgina V. Long, Andrew J. Spillane, Robyn P.M. Saw, Alexander M. Menzies, Mark B. Faries, Sapna Pradyuman Patel, Mario Mandala, Daniela Massi, Andrew Barbour, Julia Elizabeth Lai-Kwon, Chi Kin Law, Thomas E. Pennington, Sydney Ch'ng, Kerwin Frank Shannon, Robert V. Rawson, Monica Osorio, Helen Rizos, Serigne N. Lo, Alexander Christopher Jonathan van Akkooi
Institutions: Melanoma Institute Australia, The University of Sydney, Royal North Shore Hospital, Royal Prince Alfred Hospital, Angeles Clinic and Research Institute, University of Colorado Cancer Center, University of Perugia, University of Florence, The University of Queensland, Peter MacCallum Cancer Centre, Chris O’Brien Lifehouse, Macquarie University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162681364
Cites:
Cited by:
Related to: